VYNE Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2016 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
VYNE Therapeutics Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2016 to Q2 2024.
  • VYNE Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 14.5M shares, a 343% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 14.5M +11.3M +343% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 14.3M +11M +337% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 14.1M +10.9M +337% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 3.3M -54.7M -94.3% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 3.28M -54.7M -94.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 3.27M -54.6M -94.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 3.23M +253K +8.51% Dec 31, 2022 10-K 2024-03-01
Q3 2022 58M +4.53M +8.46% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 58M +6.49M +12.6% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 57.9M +6.52M +12.7% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 2.98M -40.2M -93.1% Dec 31, 2021 10-K 2023-03-14
Q3 2021 53.5M -114M -68.1% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 51.5M -116M -69.3% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 51.4M -10.1M -16.4% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 43.2M +34.1M +374% Dec 31, 2020 10-K 2022-03-17
Q3 2020 168M +144M +600% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 168M +144M +600% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 61.5M +37.8M +160% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 9.12M -14.1M -60.7% Dec 31, 2019 10-K 2021-03-04
Q3 2019 24M +752K +3.24% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 23.9M +966K +4.21% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 23.7M +694K +3.02% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 23.2M +17.9M +338% Dec 31, 2018 10-K 2020-03-03
Q3 2018 23.2M Sep 30, 2018 10-Q 2018-11-07
Q2 2018 23M Jun 30, 2018 10-Q 2018-08-01
Q1 2018 23M Mar 31, 2018 10-Q 2018-05-09
Q4 2017 5.3M +18.5K +0.35% Dec 31, 2017 10-K 2019-02-28
Q4 2016 5.28M Dec 31, 2016 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.